Is brain natriuretic peptide a reliable biomarker of hydration status in all peritoneal dialysis patients?

Blood Purification

Volumn 37, Issue 3, 2014, Pages 238-242

  Crepaldi, Carlo ^a,b   Rosner, Mitchel ^c   Teixeira, Catarina ^b   Martos, Lourdes Blanca ^b   Martino, Francesca Katiana ^a,b   Rodighiero, Maria Pia ^a,b   Ronco, Claudio ^a,b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b International Renal Research Institute Vicenza   (Italy)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bioimpedance spectroscopy; Brain natriuretic peptide; Hydration status; Peritoneal dialysis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIOIMPEDANCE SPECTROSCOPY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; AGED; BLOOD SAMPLING; CHEMILUMINESCENCE IMMUNOASSAY; DIALYSATE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; HYDRATION STATUS; RENAL SYSTEM PARAMETERS; BLOOD; DEHYDRATION; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; DEHYDRATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES;

EID: 84902301914     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000362155     Document Type: Article

References (25)

1. Krediet RT: Dry body weight: water and sodium removal targets in PD. Contrib Nephrol. Basel, Karger, 2006, vol 150, pp 104-110. (Pubitemid 44155339)
2. Woodrow G, Devine Y, Cullen M, Lindley E: Application of bioelectrical impedance to clinical assessment of body composition in peritoneal dialysis. Perit Dial Int 2007; 27: 496-502. (Pubitemid 351176007)
3. Konings CJ, Kooman JP, Schonck M, Cox-Reijven PL, van Kreel B, Gladziwa U, Wirtz J, Gerlag PG, Hoorntje SJ, Wolters J, Heidendal GA, van der Sande FM, Leunissen KM: Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int 2002; 22:683-692. (Pubitemid 36131498)
4. Wabel P, Chamney P, Moissl U, Jirka T: Importance of whole-body bioimpedance spec-troscopy for the management of fluid balance. Blood Purif 2009; 27:75-80.
5. Woodrow G, Ronco C: Assessment of fluid status in peritoneal dialysis. Contrib Nephrol. Basel, Karger, 2012, vol 178, pp 164-168.
6. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC: Pre-discharge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43:635-641. (Pubitemid 38229537)
7. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr: Biology of the natriuretic peptides. Am J Cardiol 2008; 101:3-8.
8. Naganuma T, Sugimura K, Wada S, Yasumo-to R, Sugimura T, Masuda C, Uchida J, Naka-tani T: The prognostic role of brain natriuret-ic peptides in hemodialysis patients. Am J Nephrol 2002; 22:437-444. (Pubitemid 36158501)
9. Paniagua R, Amato D, Mujais S, Vonesh E, Ramos A, Correa-Rotter R, Horl WH: Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol 2008; 3:407-415.
10. Paniagua R, Ventura MD, Avila-Diaz M, Hi-nojosa-Heredia H, Mendez-Duran A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, Garcia-Contreras F, Trinidad-Ramos P, Vazquez R, Ilabaca B, Alcantara G, Amato D: NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 2010; 25: 551-557.
11. Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE: N-termi-nal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol 2007; 18:321-330. (Pubitemid 46053444)
12. Zoccali C, Mallamaci F, Benedetto FA, Tri-pepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12:1508-1515. (Pubitemid 32666334)
13. Fagugli RM, Palumbo B, Ricciardi D, Pasini P, Santirosi P, Vecchi L, Pasticci F, Palumbo R: Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003; 95:c60-c66.
14. Gangji AS, Helal BA, Churchill DN, Brimble KS, Margetts PJ: Association between N-ter-minal propeptide B-type natriuretic peptide and markers of hypervolemia. Perit Dial Int 2008; 28:308-311. (Pubitemid 352003047)
15. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ: Plasma brain natriuretic peptide concentration on assessment of hydration status in he-modialysis patient. Am J Kidney Dis 2003; 41: 1257-1266. (Pubitemid 36637982)
16. Papakrivopoulou E, Lillywhite S, Davenport A: Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients? Nephrol Dial Transplant 2012; 27:396-401.
17. Haapio M, Honkanen E, Ronco C: Brain na-triuretic peptide in peritoneal dialysis patients. Contrib Nephrol. Basel, Karger, 2009, vol 163, pp 110-116.
18. Wabel P, Moissl U, Chamney P, Jirka T, Ma-chek P, Ponce P, Taborsky P, Tetta C, Velasco N, Vlasak J, Zaluska W, Wizemann V: Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23:2965-2971.
19. Crepaldi C, Lamas EI, Martino FK, Rodighie-ro MP, Scalzotto E, Wojewodzka-Zelezniako-wicz M, Rosner MH, Ronco C: Bioimpedance and brain natriuretic peptide in peritoneal dialysis patients. Contrib Nephrol. Basel, Kar-ger, 2012, vol 178, pp 174-181.
20. Konings CJ, Kooman JP, Schonck M, Dam-mers R, Cheriex E, Palmans Meulemans AP, Hoeks AP, van Kreel B, Gladziwa U, van der Sande FM, Leunissen KM: Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-487. (Pubitemid 35012264)
21. Van Biesen W, Williams JD, Covic AC, Fan S, Claes K, Lichodziejewska- Niemierko M, Verger C, Steiger J, Schoder V, Wabel P, Gau-ly A, Himmele R: Fluid status in peritoneal dialysis patients: The European Body Composition Monitoring (EuroBCM) study cohort. PLoS One 2011; 6:e17148.
22. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET: Association between serum N-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006; 26: 360-365.
23. Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE: Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Nephrol Dial Transplant 2009; 24: 1962-1969.
24. Heimburger O, Wang T, Lindholm B: Alterations in water and solute transport with time on peritoneal dialysis. Perit Dial Int 1999; 19(suppl 2):S83-S90. (Pubitemid 30015457)
25. Wang AY, Woo J, Wang M, Sea MM, Sanderson JE, Lui SF, Li PK: Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20:396-403. (Pubitemid 40276898)